|Articles|November 1, 2016
- Pharmaceutical Executive-11-01-2016
- Volume 36
- Issue 11
Pharmaceutical Executive, November 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Pharm Exec's 2017 Pipeline Reportalmost 9 years ago
Digital Disruption is Coming: Are You Ready?almost 9 years ago
8 Winning Commercial Portfolio Strategiesalmost 9 years ago
Building Market Access Competencies for the Futurealmost 9 years ago
Loss of Exclusivity: Strategies to Maximize Product Valuealmost 9 years ago
Flipping the Generics Map: Apotex's Jeremy Desaialmost 9 years ago
The Pipeline: Pressures from Beyondalmost 9 years ago
Has Gastein Peaked?almost 9 years ago
Country Report: SwitzerlandNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics
2
Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform
3
AstraZeneca to Announce Deal with Trump Administration: Report
4
FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma
5
